ZMAT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.938200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.565800E-01
Normal-vs-Stage2
7.404200E-01
Normal-vs-Stage3
4.511200E-01
Normal-vs-Stage4
4.664800E-01
Stage1-vs-Stage2
3.723200E-01
Stage1-vs-Stage3
3.705000E-01
Stage1-vs-Stage4
3.665800E-01
Stage2-vs-Stage3
3.222800E-01
Stage2-vs-Stage4
7.262000E-02
Stage3-vs-Stage4
1.757160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.033000E-01
Normal-vs-AfricanAmerican
3.932600E-01
Normal-vs-Asian
7.544800E-01
Caucasian-vs-AfricanAmerican
4.565200E-01
Caucasian-vs-Asian
7.508200E-01
AfricanAmerican-vs-Asian
8.093400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.847000E-01
Normal-vs-Female
8.005000E-01
Male-vs-Female
9.685400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.553000E-01
Normal-vs-Age(41-60Yrs)
6.637400E-01
Normal-vs-Age(61-80Yrs)
5.319000E-01
Normal-vs-Age(81-100Yrs)
5.089400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.175200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.696800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.001800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.213400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.075550E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.097000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.974000E-01
Normal-vs-Daily Drinker
7.707600E-01
Normal-vs-Weekly Drinker
4.025800E-01
Normal-vs-Occasional Drinker
5.199400E-01
Normal-vs-Social Drinker
7.607000E-01
Non Drinker-vs-Daily Drinker
9.870800E-01
Non Drinker-vs-Weekly Drinker
4.047400E-01
Non Drinker-vs-Occasional Drinker
7.731900E-02
Non Drinker-vs-Social Drinker
9.389000E-01
Daily Drinker-vs-Weekly Drinker
3.537000E-01
Daily Drinker-vs-Occasional Drinker
6.879600E-02
Daily Drinker-vs-Social Drinker
9.454600E-01
Weekly Drinker-vs-Occasional Drinker
1.574090E-02
Weekly Drinker-vs-Social Drinker
3.022200E-01
Occasional Drinker-vs-Social Drinker
8.848500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.648960E-01
Normal-vs-Grade 2
2.698400E-02
Normal-vs-Grade 3
1.577960E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.991600E-02
Grade 1-vs-Grade 3
1.732390E-02
Grade 1-vs-Grade 4
1.648960E-01
Grade 2-vs-Grade 3
4.821000E-01
Grade 2-vs-Grade 4
2.698400E-02
Grade 3-vs-Grade 4
1.577960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.690000E-01
Normal-vs-NonDiabetic
8.349400E-01
Diabetic-vs-NonDiabetic
7.591000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.639600E-01
Normal-vs-NoPancreatitis
8.026200E-01
Pancreatitis-vs-NoPancreatitis
2.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.574400E-01
Normal-vs-N1
7.399000E-01
N0-vs-N1
3.001600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.880000E-01
Normal-vs-TP53-NonMutant
7.283200E-01
TP53-Mutant-vs-TP53-NonMutant
2.876300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
